These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 11848436)

  • 1. Risk of recurrent venous thomboembolism--expanding the frontier.
    Prins MH; Marchiori A
    Thromb Haemost; 2002 Jan; 87(1):1-3. PubMed ID: 11848436
    [No Abstract]   [Full Text] [Related]  

  • 2. Risk of venous thromboembolism recurrence: high negative predictive value of D-dimer performed after oral anticoagulation is stopped.
    Palareti G; Legnani C; Cosmi B; Guazzaloca G; Pancani C; Coccheri S
    Thromb Haemost; 2002 Jan; 87(1):7-12. PubMed ID: 11848459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mapping out the future in venous thromboembolism and acute coronary syndromes.
    Heit JA
    Semin Thromb Hemost; 2002 Aug; 28 Suppl 3():33-9. PubMed ID: 12232821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Venous thromboembolism in pregnancy.
    James AH
    Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):326-31. PubMed ID: 19228606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrence rate after a first venous thrombosis in patients with familial thrombophilia.
    Vossen CY; Walker ID; Svensson P; Souto JC; Scharrer I; Preston FE; Palareti G; Pabinger I; van der Meer FJ; Makris M; Fontcuberta J; Conard J; Rosendaal FR
    Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1992-7. PubMed ID: 15976329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Venous thromboembolism in the ICU and reversal of bleeding on anticoagulants.
    DeLoughery TG
    Crit Care Clin; 2005 Jul; 21(3):497-512. PubMed ID: 15992670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thromboembolic diseases.
    Wakefield TW; Caprini J; Comerota AJ
    Curr Probl Surg; 2008 Dec; 45(12):844-99. PubMed ID: 18984095
    [No Abstract]   [Full Text] [Related]  

  • 8. Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments.
    De Stefano V; Za T; Rossi E; Vannucchi AM; Ruggeri M; Elli E; Micò C; Tieghi A; Cacciola RR; Santoro C; Gerli G; Vianelli N; Guglielmelli P; Pieri L; Scognamiglio F; Rodeghiero F; Pogliani EM; Finazzi G; Gugliotta L; Marchioli R; Leone G; Barbui T;
    Haematologica; 2008 Mar; 93(3):372-80. PubMed ID: 18268279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Update on current care guidelines. Deep thrombosis and pulmonary embolism].
    Lassila R; Halinen M; Harjola VP; Kaaja R; Kunnamo I; Manninen H; Melin J; Mustonen P; Pohjola-Sintonen S; Puurunen M; Sinisalo J; Teittinen J
    Duodecim; 2005; 121(9):1001-2. PubMed ID: 15991745
    [No Abstract]   [Full Text] [Related]  

  • 10. [Epidemiology of venous thrombosis].
    Emmerich J
    Bull Acad Natl Med; 2003; 187(1):19-32; discussion 32-3. PubMed ID: 14556451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Venous thromboembolism during pregnancy or postpartum: findings from the RIETE Registry.
    Blanco-Molina A; Trujillo-Santos J; Criado J; Lopez L; Lecumberri R; Gutierrez R; Monreal M;
    Thromb Haemost; 2007 Feb; 97(2):186-90. PubMed ID: 17264945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Venous thromboembolism: risk factors for recurrence.
    Zhu T; Martinez I; Emmerich J
    Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):298-310. PubMed ID: 19228602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Initial results of the PROTECT Study publicized. Stroke patients need effective thrombosis prevention].
    Diener HC
    MMW Fortschr Med; 2005 Jun; 147(22):50. PubMed ID: 15977636
    [No Abstract]   [Full Text] [Related]  

  • 14. Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients.
    Leizorovicz A; Cohen AT; Turpie AG; Olsson CG; Vaitkus PT; Goldhaber SZ;
    Circulation; 2004 Aug; 110(7):874-9. PubMed ID: 15289368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Venous thromboembolism: "... an ounce of prevention is worth a pound of cure".
    Goldhaber SZ; Ageno W
    Thromb Haemost; 2015 Jun; 113(6):1174-5. PubMed ID: 25947622
    [No Abstract]   [Full Text] [Related]  

  • 16. [Therapy of pulmonary embolism. Rivaroxaban is superior to standard therapy].
    Einecke D
    MMW Fortschr Med; 2012 Apr; 154(7):24. PubMed ID: 22558862
    [No Abstract]   [Full Text] [Related]  

  • 17. Thrombophilic abnormalities and recurrence of venous thromboembolism in patients treated with standardized anticoagulant treatment.
    Santamaria MG; Agnelli G; Taliani MR; Prandoni P; Moia M; Bazzan M; Guazzaloca G; Ageno W; Bertoldi A; Silingardi M; Tomasi C; Ambrosio GB;
    Thromb Res; 2005; 116(4):301-6. PubMed ID: 16038714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors for recurrence of venous thromboembolism (VTE) or bleeding during long-term secondary prevention of VTE with ximelagatran.
    Eriksson H; Lundström T; Wåhlander K; Clason SB; Schulman S;
    Thromb Haemost; 2005 Sep; 94(3):522-7. PubMed ID: 16268466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What is the optimal pharmacological prophylaxis for the prevention of deep-vein thrombosis and pulmonary embolism in patients with acute ischemic stroke?
    Kamphuisen PW; Agnelli G
    Thromb Res; 2007; 119(3):265-74. PubMed ID: 16674999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk assessment and novel therapeutic approaches: reducing the incidence and recurrence of deep vein thrombosis in the surgical patient. Conclusion.
    Laird L; Wille-Jørgensen P
    Orthopedics; 2000 Jun; 23(6 Suppl):s655-6. PubMed ID: 10875432
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.